Alcon AG | ALC - Current Assets


Alcon AG reported $6.45B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AstraZeneca USD 28.72B 1.22B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Essilor EUR 12.01B 981M Dec/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Fresenius Medical Care EUR 7.9B 74M Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.23B 354M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Philips EUR 9.93B 654M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025
Sonova Holding CHF 1.91B 466.3M Jun/2025
UCB EUR 6.05B 733M Dec/2025